Wolfgang Erl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wolfgang Erl has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Christian Weber
Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität (LMU) München, Munich, Germany
4 shared publications - Jiri Neuzil
Institute of Biotechnology, Czech Academy of Sciences, Prague-West 252 50, Czech Republic; Faculty of Science, Charles University, Prague 128 00, Czech Republic; First Faculty of Medicine, Charles University, Prague 128 00, Czech Republic; Malaghan Institute of Medical Research, Wellington 6242, New Zealand; School of Pharmacy and Medical Science, Griffith University, Southport, Queensland 4222, Australia
2 shared publications Peter C Weber
2 shared publications- Alexei Terman
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm SE-141 86, Huddinge, Sweden
1 shared publication - Alma Zernecke
University Hospital Würzburg, Institute of Clinical Biochemistry and Pathobiochemistry, Würzburg, GERMANY
1 shared publication Andreas Schröder
1 shared publication
Latest Publications
- Open Access
- 19 December 2003
- Published by Wiley in European Journal of Immunology
- Vol. 34 (1) , 241-250
Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-γ
- 19 December 2003
- Published by Wiley in European Journal of Immunology
- Vol. 34 (1) , 241-250
Open AccessCyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-γ
- 1 August 2003
- Published by Elsevier in Atherosclerosis
- Vol. 169 (2) , 251-258
HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells
- 1 August 2003
- Published by Elsevier in Atherosclerosis
- Vol. 169 (2) , 251-258
HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells
- 1 March 2002
- Vol. 8 (3) , 863-9
Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Alpha-tocopheryl succinate (alpha-TOS), a redox-inactive analogue of vitamin E, is a strong inducer of apoptosis, whereas alpha-tocopherol (alpha-TOH) lacks apoptogenic activity (J. Neuzil et al., FASEB J., 15: 403-415, 2001). Here we investigated the possible antineoplastic activities of alpha-TOH and alpha-TOS and further explored the potential of alpha-TOS as an antitumor agent. Using nude mice with colon cancer xenografts, we found that alpha-TOH exerted modest antitumor activity and acted by inhibiting tumor cell proliferation. In contrast, alpha-TOS showed a more profound antitumor effect, at both the level of inhibition of proliferation and induction of tumor cell apoptosis. alpha-TOS was nontoxic to normal cells and tissues, triggered apoptosis in p53(-/-) and p21(Waf1/Cip1(-/-)) cancer cells, and exerted a cooperative proapoptotic activity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) due to differences in proapoptotic signaling. Finally, alpha-TOS cooperated with tumor necrosis factor-related apoptosis-inducing ligand in suppression of tumor growth in vivo. Vitamin E succinate is thus a potent and highly specific anticancer agent and/or adjuvant of considerable therapeutic potential.
- 1 March 2002
- Vol. 8 (3) , 863-9
Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Alpha-tocopheryl succinate (alpha-TOS), a redox-inactive analogue of vitamin E, is a strong inducer of apoptosis, whereas alpha-tocopherol (alpha-TOH) lacks apoptogenic activity (J. Neuzil et al., FASEB J., 15: 403-415, 2001). Here we investigated the possible antineoplastic activities of alpha-TOH and alpha-TOS and further explored the potential of alpha-TOS as an antitumor agent. Using nude mice with colon cancer xenografts, we found that alpha-TOH exerted modest antitumor activity and acted by inhibiting tumor cell proliferation. In contrast, alpha-TOS showed a more profound antitumor effect, at both the level of inhibition of proliferation and induction of tumor cell apoptosis. alpha-TOS was nontoxic to normal cells and tissues, triggered apoptosis in p53(-/-) and p21(Waf1/Cip1(-/-)) cancer cells, and exerted a cooperative proapoptotic activity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) due to differences in proapoptotic signaling. Finally, alpha-TOS cooperated with tumor necrosis factor-related apoptosis-inducing ligand in suppression of tumor growth in vivo. Vitamin E succinate is thus a potent and highly specific anticancer agent and/or adjuvant of considerable therapeutic potential.
- 1 October 2001
- Published by Elsevier in Atherosclerosis
- Vol. 158 (2) , 491-493
Transient increase of monocyte adhesion after a single dose of simvastatin
- 1 October 2001
- Published by Elsevier in Atherosclerosis
- Vol. 158 (2) , 491-493
Transient increase of monocyte adhesion after a single dose of simvastatin
- 1 June 2000
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 278 (6) , C1116-C1125
Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu2+ and Zn2+
Pyrrolidine dithiocarbamate (PDTC) has been found to induce or inhibit apoptosis in different cell types. Here we show that PDTC dose-dependently reduced the viability of rat smooth muscle cells (rSMC), human fibroblasts, and endothelial cells at low but not at high cell density. Endothelial cells were least sensitive, fibroblasts showed a medium sensitivity, and rSMC showed a high sensitivity to PDTC-mediated cell death. An early reduction in the mitochondrial membrane potential indicated a rapid onset of apoptosis in rSMC. Apoptosis was further confirmed by annexin V staining and DNA fragmentation analysis. Gel shift analysis demonstrated increased nuclear factor (NF)-κB activity in high-density rSMC compared with low-density cells. NF-κB has recently been shown to regulate the induction of anti-apoptotic proteins. Although PDTC is widely used as an inhibitor for NF-κB and a radical scavenger, our data show that PDTC rather enhanced NF-κB activity and, alone or in combination with menadione, induced oxygen radical generation. Notably, PDTC failed to reduce rSMC viability in medium without Cu2+ or Zn2+, and addition of Cu2+ or Zn2+resulted in a dose-dependent increase in PDTC-induced cell death. Addition of both Cu2+ and Zn2+ showed synergistic effects. Our results indicate that the induction of apoptosis by PDTC requires Cu2+ and Zn2+ and is dependent on cell type and density. Such differential effects may have implications for studies of PDTC as an anti-atherosclerotic or immunomodulatory drug.
- 1 June 2000
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 278 (6) , C1116-C1125
Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu2+ and Zn2+
Pyrrolidine dithiocarbamate (PDTC) has been found to induce or inhibit apoptosis in different cell types. Here we show that PDTC dose-dependently reduced the viability of rat smooth muscle cells (rSMC), human fibroblasts, and endothelial cells at low but not at high cell density. Endothelial cells were least sensitive, fibroblasts showed a medium sensitivity, and rSMC showed a high sensitivity to PDTC-mediated cell death. An early reduction in the mitochondrial membrane potential indicated a rapid onset of apoptosis in rSMC. Apoptosis was further confirmed by annexin V staining and DNA fragmentation analysis. Gel shift analysis demonstrated increased nuclear factor (NF)-κB activity in high-density rSMC compared with low-density cells. NF-κB has recently been shown to regulate the induction of anti-apoptotic proteins. Although PDTC is widely used as an inhibitor for NF-κB and a radical scavenger, our data show that PDTC rather enhanced NF-κB activity and, alone or in combination with menadione, induced oxygen radical generation. Notably, PDTC failed to reduce rSMC viability in medium without Cu2+ or Zn2+, and addition of Cu2+ or Zn2+resulted in a dose-dependent increase in PDTC-induced cell death. Addition of both Cu2+ and Zn2+ showed synergistic effects. Our results indicate that the induction of apoptosis by PDTC requires Cu2+ and Zn2+ and is dependent on cell type and density. Such differential effects may have implications for studies of PDTC as an anti-atherosclerotic or immunomodulatory drug.